TEMPISIN1234

Vivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 MillionVivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 Million

Vivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 Million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES…

2 days ago
Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025

Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025

Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025 Halle (Saale) / Munich,…

1 month ago
Vivoryon Therapeutics N.V. to Present at Upcoming Investor ConferencesVivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences Halle (Saale) / Munich, Germany, June 27, 2025 – Vivoryon Therapeutics…

3 months ago